Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-129330

Director acquired 33,410 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2024-11-19 Option exercise +33,410 $5.94 $198,455 48,010 D
Derivatives
Coleman Mark Director 2024-11-19 Option exercise · Stock Option (Right to Buy) −33,410 0 D
Loading xslF345X05/ownership.xml…